- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03675243
Quality of Life After Transanal Endoscopic Microsurgery (TEM) (QoLTEM)
January 26, 2022 updated by: State Scientific Centre of Coloproctology, Russian Federation
Quality of Life After Transanal Endoscopic Microsurgery (TEM) for Rectal Neoplasm
This is a observational cohort study to determine the influence of Transanal endoscopic microsurgery (TEM) on patients Quality of Life
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients who planning Transanal Endoscopic Microsurgery (TEM) for rectal neoplasms should undergoing fecal incontinence quality of life scale and Wexner score before and after surgery for measurement their quality of life.
For objectification data sphinctrometry will be perform.
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Moscow, Russian Federation, 123423
- State Scientific Centre of Coloproctology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 76 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with rectal neoplasms with planning transanal endoscopic microsurgery (TEM)
Description
Inclusion Criteria:
- Have a planned of Transanal endoscopic microsurgery (TEM)
- Have signed approved informed consent form for the study
Exclusion Criteria:
- non epithelial malignancy
- recurrent neoplasm
- stoma formation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fecal incontinence quality of life scale
Time Frame: 3 month
|
The FIQL is a standardized instrument that can be used to assess QOL issues related to fecal incontinence.The Fecal Incontinence Quality of Life Scale is composed of a total of 29 items; these items form four scales: Lifestyle (10 items), Coping/Behavior (9 items), Depression/Self-Perception (7 items), and Embarrassment (3 items).Each aspect is described as a score measured on a scale between 1 and 4, where 1 is very affected and 4 is not affected
|
3 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wexner score
Time Frame: 3 month
|
Wexner score is composed of a total 5 items for each type of incontinence.
Each aspect is described as a score measured on a scale between 1 and 4, where 0 is rarely, 4 - always/ 0 - perfect, 20 - complete incontinence.
|
3 month
|
|
Sphinctrometry
Time Frame: 3 month
|
Anal pressure in mmHg
|
3 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2018
Primary Completion (Actual)
March 30, 2020
Study Completion (Actual)
March 30, 2021
Study Registration Dates
First Submitted
September 12, 2018
First Submitted That Met QC Criteria
September 16, 2018
First Posted (Actual)
September 18, 2018
Study Record Updates
Last Update Posted (Actual)
January 27, 2022
Last Update Submitted That Met QC Criteria
January 26, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 85A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transanal Endoscopic Microsurgery (TEM)
-
University of MinnesotaWithdrawn
-
Kasr El Aini HospitalCompletedUltrasound | Gastric | Transanal Endoscopic Surgical Procedures | Residual VolumeEgypt
-
Sun Yat-sen UniversityActive, not recruitingLaparoscopic Surgery | Rectal Neoplasms | Neoplastic Cells, Circulating | Transanal Endoscopic SurgeryChina